SCPC Applauds PBM Provisions Included in the Consolidated Appropriations Act 2026
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement in support of PBM reform:
“SCPC strongly supports the pharmacy benefit manager (PBM) provisions included in the Consolidated Appropriations Act, 2026, and we commend Congressman Buddy Carter for his leadership in advancing meaningful PBM accountability reforms.
For years, opaque and anticompetitive PBM practices have placed unnecessary financial and administrative strain on LTC pharmacies, threatening their ability to serve seniors living in nursing homes and assisted living facilities. The PBM provisions championed by Rep. Carter take important steps toward holding PBMs accountable and ensuring greater transparency and fairness in how prescription drug benefits are administered.
By strengthening transparency requirements and reinforcing reasonable contracting standards with CMS, these provisions help LTC pharmacies secure fairer, sustainable contracts that reflect the specialized, around-the-clock care they provide to medically complex seniors. These reforms also support CMS’s ongoing efforts to monitor PBMs and preserve access to pharmacy services for vulnerable populations with the recent implementation of Medicare Part D price negotiations.
LTC pharmacies are an essential part of the senior care continuum, and these PBM reforms help protect their ability to operate, innovate, and continue serving patients who rely on them every day. We urge Congress to advance these bipartisan provisions as part of the January funding package and to continue working with CMS and stakeholders to ensure PBMs are subject to appropriate oversight and accountability, keeping patients, not profits, at the center of the healthcare system,” said Alan Rosenbloom, President/CEO of SCPC.
# # #
Recent Posts
-
NCPA Advocates for Medicare Drug Price Negotiation Program Overhaul Due to Pharmacy Cash Flow
With its initial rollout beginning in 2026, the Medicare Drug Price Negotiation Program has caused significant strain on the cash flow of independent pharmacies.
The National Community Pharmacists Association (NCPA) is sounding the alarm over the federal government’s implementation of the Medicare Drug Price Negotiation Program (MDPNP) after a recent survey of its members revealed significant financial distress, according to a news release.
-
Pharmacies To Face Low Cash Flow For MFP Drugs Until Fixes Emerge
A bill introduced last year aiming to ensure long-term care (LTC) pharmacies can continue to supply and dispense Medicare Part D drugs despite lower prices resulting from the price negotiation program will need to be tweaked to ensure the intended relief is retroactive, according to Alan Rosenbloom, executive director of the Senior Care Pharmacy Coalition (SCPC).
-
SCPC Applauds Inclusion of PBM Reform in Recent Spending Package Approved by U.S. House & Senate
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement about the passage of PBM reform: “SCPC applauds the passage of bipartisan pharmacy benefit manager (PBM) reform legislation by both the U.S. House and Senate, marking a significant step toward greater transparency, accountability, and fairness in the prescription drug marketplace. These […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.